Tag ~clinical trial

Tag descriptions coming soon to Wherrelz News!


Trialjectory on track to match 50K cancer patients with clinical trials this year: 35 are from underrepresented groups

3D Printed Drug Delivery Implant Achieves Successful Clinical Trial for Parkinsons Disease

Global eClinical Trial Solutions Market Expected to Deliver Dynamic Progression Until 2025

3D Printing News Briefs: December 22 2017

BioNTech founder Uur ahin and Mayfields Ursheet Parikh are coming to Disrupt

UnlearnAI nabs 12M to build digital twins to speed up and improve clinical trials

Vinehealth offering digital support for cancer patients and SaaS for RD gets 55M to launch in the US

Truveta is making progress towards building a living medical portrait of America

The Advent of Intraoperative Bioprinting is Here Thanks to Penn State Researchers

Seattle Genetics stock jumps 17 on breast cancer drug trial success

Clinical Trial Supplies Market Demand Growth Challenges Industry Analysis And Forecasts to 2027

4G Clinicals clinical trial management software attracts over 200M in new funding

Auxilius lands 10M to help biopharmas manage financial aspects of the clinical trial process

Early cancerdetection startup Grail is reportedly trying to raise more money

Global Clinical Trial Management System Market is growing at a CAGR of 109 from 2018 to 2025

Johnson Johnsons COVID19 vaccine is 85 effective against severe cases and 66 effective overall per trial data

Curebase thinks the future of clinical testing is decentralized and raises 40M to prove it

Clinical Trial Management System Market is growing at a CAGR of 109 from 2018 to 2025

Castor a clinical trial process company raises 45M to create more humancentered research

3D Printing News Briefs April 22 2021: Philips Lighting Cerambot Revotek UTHSC ENS Lyon Universit de Lorraine University of Victoria

UnlearnAI a startup developing a digital twin service for clinical trials raises 50M

Medable reaches 21B valuation as Tiger Blackstone GSR pump new capital into clinical trials management company

Moderna says its making variantspecific COVID19 vaccines but its existing vaccine should still work